Get started
Author

Milad Khedr

Observed names: Khedr M, Khedr, Milad, M. Khedr, Milad KHEDR
ORCID: 0000-0002-4998-2397
Observed ORCID: 0000-0002-4998-2397
OpenAlex ID: A5050059249
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial
2020 · Lakshminarayan R Ranganath, Eftychia Eirini Psarelli, et al. · The Lancet Diabetes & Endocrinology · 132
Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre
2018 · L.R. Ranganath, M. Khedr, et al. · Molecular Genetics and Metabolism · 102
PDF
The effect of nitisinone on homogentisic acid and tyrosine: a two-year survey of patients attending the National Alkaptonuria Centre, Liverpool
2017 · Anna M Milan, Andrew T Hughes, et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 43
Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network
2023 · Alberico L. Catapano, Lale Tokgözoğlu, et al. · Atherosclerosis · 31
PDF
Asymptomatic Corneal Keratopathy Secondary to Hypertyrosinaemia Following Low Dose Nitisinone and a Literature Review of Tyrosine Keratopathy in Alkaptonuria
2017 · M. Khedr, S. Judd, et al. · JIMD Reports · 29
PDF
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria
2019 · Lakshminarayan R. Ranganath, Anna M. Milan, et al. · Journal of Inherited Metabolic Disease · 28
PDF
Subclinical ochronosis features in alkaptonuria: a cross-sectional study
2019 · Trevor Cox, Eftychia Eirini Psarelli, et al. · BMJ Innovations · 25
PDF
Reversal of ochronotic pigmentation in alkaptonuria following nitisinone therapy: Analysis of data from the United Kingdom National Alkaptonuria Centre
2020 · Lakshminarayan R. Ranganath, Anna M. Milan, et al. · JIMD Reports · 23
PDF
Nitisinone causes acquired tyrosinosis in alkaptonuria
2020 · Milad Khedr, Maggie S. Cooper, et al. · Journal of Inherited Metabolic Disease · 23
PDF
Quantification of the flux of tyrosine pathway metabolites during nitisinone treatment of Alkaptonuria
2019 · A. M. Milan, A. T. Hughes, et al. · Scientific Reports · 23
PDF
The nutritional status of people with alkaptonuria: An exploratory analysis suggests a protein/energy dilemma
2020 · Shirley Judd, Milad Khedr, et al. · JIMD Reports · 19
PDF
Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinone
2018 · R. Griffin, E.E. Psarelli, et al. · Data in Brief · 19
Comparing nitisinone 2 mg and 10 mg in the treatment of alkaptonuria—An approach using statistical modelling
2021 · Lakshminarayan R. Ranganath, Anna M. Milan, et al. · JIMD Reports · 18
Frequency, diagnosis, pathogenesis and management of osteoporosis in alkaptonuria: data analysis from the UK National Alkaptonuria Centre
2020 · L. R. Ranganath, M. Khedr, et al. · Osteoporosis International · 17
Assessment of the Effect of Once Daily Nitisinone Therapy on 24-h Urinary Metadrenalines and 5-Hydroxyindole Acetic Acid Excretion in Patients with Alkaptonuria After 4 Weeks of Treatment
2017 · A. S. Davison, B. Norman, et al. · JIMD Reports · 17
Clinical and biochemical assessment of depressive symptoms in patients with Alkaptonuria before and after two years of treatment with nitisinone
2018 · A.S. Davison, J.A. Harrold, et al. · Molecular Genetics and Metabolism · 15
Evaluation of the serum metabolome of patients with alkaptonuria before and after two years of treatment with nitisinone using LC‐QTOF‐MS
2019 · Andrew S. Davison, Brendan P. Norman, et al. · JIMD Reports · 14
PDF
Serum Amino Acid Profiling in Patients with Alkaptonuria Before and After Treatment with Nitisinone
2018 · A. S. Davison, B. P. Norman, et al. · JIMD Reports · 14
Prolonged hypocalcaemia following a single dose of 60 mg denosumab in two patients with CKD 4/5 on cinacalcet treatment for tertiary hyperparathyroidism
2013 · P. Ivanov, M. Khedr · Clinical Kidney Journal · 11
PDF
Vitiligo, alkaptonuria, and nitisinone—A report of three families and review of the literature
2021 · Lakshminarayan Ranganath, Milad Khedr, et al. · JIMD Reports · 10
PDF
Radiological evolution of spinal disease in alkaptonuria and the effect of nitisinone
2022 · Richard Imrich, Jana Sedláková, et al. · RMD Open · 9
PDF
Temporal Adaptations in the Phenylalanine/Tyrosine Pathway and Related Factors During Nitisinone-Induced Tyrosinaemia in Alkaptonuria
2022 · L.R. Ranganath, A.T. Hughes, et al. · Molecular Genetics and Metabolism · 9
Treatment of osteoporotic fractures in alkaptonuria by teriparatide stimulates bone formation and decreases fracture rate – A report of two cases
2021 · L.R. Ranganath, M. Khedr, et al. · Bone Reports · 9
PDF
Characterizing the alkaptonuria joint and spine phenotype and assessing the effect of homogentisic acid lowering therapy in a large cohort of 87 patients
2021 · Lakshminarayan R. Ranganath, Milad Khedr, et al. · Journal of Inherited Metabolic Disease · 9
Association of alkaptonuria and low dose nitisinone therapy with cataract formation in a large cohort of patients
2022 · Mohammad S. Z. Ahmad, Mahmoud Ahmed, et al. · JIMD Reports · 8
Works count: 46
Citation count: 699
H-index: 15
I10-index: 20
Year
Topic
Type